Diseases, Conditions, Syndromes

Efpeglenatide lowers risk for adverse CV events in T2DM

(HealthDay)—For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based glucagon-like peptide ...

Medical research

Sunflower peptide as template for potential analgesic

A naturally occurring peptide in sunflower seeds was synthetically optimized and has now been identified as a potential drug for treating abdominal pain or inflammation (in the gastrointestinal tract, abdominal area and/or ...

Cardiology

Combining low-salt, DASH diets may reduce cardiac damage

(HealthDay)—Dietary interventions, like the Dietary Approaches to Stop Hypertension (DASH) diet and low sodium consumption, can improve cardiovascular risk factors in a relatively short time period, according to a study ...

page 7 from 40